Speciality: Hematology
Description:
A warm welcome to all the medical professionals to this highly anticipated panel discussion on "An Eagle's View - Evidence-based Discussion on Iron Deficiency Anemia." Following our in-depth look at IDA, this session offers a unique opportunity for a dynamic and interactive exchange among experts. The goal is to address the multifaceted challenges in diagnosing and treating IDA in various patient populations, from managing comorbidities to navigating treatment resistance.
This panel will delve into pressing questions that arise in clinical practice. Topics will include the most effective strategies for iron repletion in patients with chronic inflammatory conditions, such as inflammatory bowel disease, where oral iron absorption is often impaired. The experts will also discuss the optimal use of intravenous iron formulations, considering factors like dosing, patient safety, and the cost-benefit analysis in different healthcare settings. This discussion will highlight the importance of personalized, evidence-based decision-making.
Therefore, get an overall knowledge of how to apply an evidence-based approach to the complexities of iron deficiency anemia in a panel discussion format. Absorb the shared knowledge, get your questions answered by experts, and follow Hidoc for more such insightful webinar sessions.
See More Webinars @ Hidoc Webinars
1.
A BRAF V600E mutation-positive intrathoracic synovial sarcoma is reported by researchers.
2.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
3.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
4.
An inoperable locally advanced NSCLC trial dubbed "Practice Changing".
5.
CDC Alerts on Dramatic Rise in Human Parvovirus B19
1.
All You Need To Know About Partial Thromboplastin Time (PTT) Test
2.
Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights
3.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
4.
Rasburicase-Linked Methemoglobinemia in HCC: Risks, Mechanisms, and Management
5.
Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Navigating the Complexities of Ph Negative ALL - Part IV
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Navigating the Complexities of Ph Negative ALL - Part XII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation